FGFR3 and plasma cell myeloma: In particular, activating FGFR3 mutations have been associated with growth arrest in chondrocytes, whereas they enhance proliferation and/or transformation in several cancer types and skin disorders (e.g. bladder cancer, multiple myeloma, seborrheic keratosis, etc.)[79].